Garcinol acts as an antineoplastic agent in human gastric cancer by inhibiting the PI3K/AKT signaling pathway

Gastric cancer (GC) is one of the most common malignancies worldwide; however, treatment options other than surgery remain limited. Neoadjuvant chemotherapy has the potential to suppress of gastric tumorigenesis. Garcinol has been reported to exert inhibitory effects on the progression of numerous carcinomas. However, its effects in GC remain unclear. Therefore, the aim of the present study was to investigate the effects of garcinol on the proliferation, invasion and apoptosis of gastric carcinoma cells and then to explore the underlying mechanisms. Garcinol significantly decreased the proliferation and invasion of GC cells and increased apoptosis in a dose-dependent manner. Additionally, the expression of AKTp-Thr308, cyclin D1, Bcl-2, BAX, matrix metalloprotease (MMP-2) and MMP-9 in HGC-27 cells following treatment with garcinol. The results obtained in the present study suggested that garcinol may inhibit gastric tumorigenesis by suppressing the PI3K/AKT signaling pathway.

• Publication year

  2020

• Venue

  Oncology Letters

• Publication date

  2020-05-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/ol.2020.11585PMID 32565991PMCID 7285879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Down-regulation of HIF-1α inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression

  2018cited by this paper
• Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k‐Akt signaling pathway

  2018cited by this paper
• Research on the mechanism of HP mediated PI3K/AKT/GSK3β pathways in gastric cancer.

  2017cited by this paper
• The C8 side chain is one of the key functional group of Garcinol for its anti-cancer effects.

  2017cited by this paper
• Progress in the treatment of advanced gastric cancer

  2017cited by this paper
• Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells

  2017cited by this paper
• G1 cyclins protect pluripotency

  2017cited by this paper
• CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.

  2016cited by this paper
• Garcinol inhibits tumour cell proliferation, angiogenesis, cell cycle progression and induces apoptosis via NF-κB inhibition in oral cancer

  2016cited by this paper
• The PI3K/AKT Pathway as a Target for Cancer Treatment.

  2016cited by this paper
• The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines

  2016cited by this paper
• Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer

  2016cited by this paper
• Gastric cancer

  2016cited by this paper
• Antitumor Activity of Garcinol in Human Prostate Cancer Cells and Xenograft Mice.

  2015cited by this paper
• Garcinol: Current status of its anti-oxidative, anti-inflammatory and anti-cancer effects.

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• mTOR coordinates protein synthesis, mitochondrial activity and proliferation

  2015cited by this paper
• Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention

  2014cited by this paper
• The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance

  2014cited by this paper
• Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo

  2014cited by this paper
• Treatment of gastric cancer.

  2014cited by this paper
• Interferon-λ1 induces G1 phase cell cycle arrest and apoptosis in gastric carcinoma cells in vitro.

  2014cited by this paper
• Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways

  2014cited by this paper
• Garcinol, a histone acetyltransferase inhibitor, radiosensitizes cancer cells by inhibiting non-homologous end joining.

  2012cited by this paper
• Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling.

  2012cited by this paper
• Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death

  2012cited by this paper
• Potential Role of Garcinol as an Anticancer Agent

  2012cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Garcinol Inhibits Cell Proliferation and Promotes Apoptosis in Pancreatic Adenocarcinoma Cells

  2011cited by this paper
• Dysregulation of cellular signaling in gastric cancer.

  2010cited by this paper
• Targeting mTOR pathway: A new concept in cancer therapy

  2010cited by this paper
• Apoptosis‐inducing effect of garcinol is mediated by NF‐κB signaling in breast cancer cells

  2010cited by this paper
• Helicobacter pylori regulates cellular migration and apoptosis by activation of phosphatidylinositol 3-kinase signaling.

  2009cited by this paper
• Morphoproteomic profile of mTOR, Ras/Raf kinase/ERK, and NF-kappaB pathways in human gastric adenocarcinoma.

  2008cited by this paper
• Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model

  2007cited by this paper
• The Bcl-2 apoptotic switch in cancer development and therapy

  2007cited by this paper
• Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through down‐regulation of Src, ERK, and Akt survival signaling in human colon cancer cells

  2005cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• PI3K/Akt signalling pathway and cancer.

  2004cited by this paper
• The Trypanosoma brucei Cyclin, CYC2, Is Required for Cell Cycle Progression through G1 Phase and for Maintenance of Procyclic Form Cell Morphology*

  2004cited by this paper
• Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

  2003cited by this paper
• Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

  2003cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Proliferation, cell cycle and apoptosis in cancer

  2001cited by this paper
• Free radical scavenging activity and antiulcer activity of garcinol from Garcinia indica fruit rind.

  2000cited by this paper
• Interleukin 3-dependent survival by the Akt protein kinase.

  1997cited by this paper
• Different roles for cyclins D1 and E in regulation of the G1-to-S transition

  1995cited by this paper

• Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential

  2025cites this paper
• Traditional Chinese Medicine in chronic atrophic gastritis and gastric cancer: Mechanisms and pathways

  2025cites this paper
• Garcinol: An emerging epigenetic modifier with versatile anticancer properties

  2025cites this paper
• Targeting NF-κB signaling cascades of glioblastoma by a natural benzophenone, garcinol, via in vitro and molecular docking approaches

  2024cites this paper
• Phytochemical characterization and evaluation of the biological activity spectrum of ethanolic fruit extract of Garcinia indica: a less explored plant of Ayurveda

  2024cites this paper
• Garcinol in gastrointestinal cancer prevention: recent advances and future prospects

  2024cites this paper
• Garcinol-Attenuated Gastric Ulcer (GU) Experimentally Induced in Rats Via Affecting Inflammation, Cell Proliferation, and DNA Polymerization

  2023cites this paper
• Anticancer and anti-Inflammatory Activities of Garcinol and Its Analogs

  2023cites this paper
• Bioactive compounds, bio-functional properties, and food applications of Garcinia indica: A review.

  2022cites this paper
• Phytochemicals and Nanoparticles in the Modulation of PI3K/ Akt/ mTOR Kinases and Its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence.

  2022cites this paper
• Diet-derived small molecules (nutraceuticals) inhibit cellular proliferation by interfering with key oncogenic pathways: an overview of experimental evidence in cancer chemoprevention

  2022cites this paper
• Gastric cancer: An epigenetic view

  2022cites this paper
• Function of selected natural antidiabetic compounds with potential against cancer via modulation of the PI3K/AKT/mTOR cascade.

  2021cites this paper
• Development of a New Nanocarrier for Dietary Garcinol: Characterization and In Vitro Efficacy Evaluation Using Breast Cancer Stem Cells Grown in Hypoxia

  2021cites this paper
• Garcinol—A Natural Histone Acetyltransferase Inhibitor and New Anti-Cancer Epigenetic Drug

  2021cites this paper
• LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis

  2020cites this paper
• LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis

  2020cites this paper
• LukS-PV Inhibits Hepatocellular Carcinoma Cells Migration via the TNNC1/PI3K/AKT Axis

  2020cites this paper